Re-Emergence of Childhood Respiratory Infections in Adults (RSV & Pertussis)

A: Respiratory Syncytial Virus infection in Adults
Part of the Emerging Infectious Diseases of the 21st Century book series (EIDC)

Respiratory syncytial virus (RSV) is a major cause of lower respiratory tract illness in young children, responsible for significant yearly morbidity and life-threatening infections in the first 2 years of life. It is a major cause of outbreaks of tracheo-bronchitis, bronchiolitis, and pneumonia in young children in the winter and spring. Nearly 100% of children worldwide will be infected with RSV by 3 years of age and 95% will have antibodies by 2 years.1 However, immunity is incomplete and short lived and reurrent infection is common. Although the attack rates are most common in infants, between 38% and 47% of older children and adults in families acquire RSV infection after exposure2 Although RSV infection in adults has been recognized for decades its importance has been overlooked until more recently.


Respiratory Syncytial Virus Lower Respiratory Tract Respiratory Syncytial Virus Infection Respiratory Virus Infection Bone Marrow Trans 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References for A

  1. 1.
    Hall, C.B., McCarthy, C.A., (2000), Respiratory Syncytial Virus, in: Principles and Practice of Infectious Diseases, 5th Edition, Mandell, G.L., Bennett, J.E., Dolin, R., (eds). Churchill Livingstone, Philadelphia, pp. 1782–1801.Google Scholar
  2. 2.
    Hall, C.B., Geiman, J.M., Biggar, R., Kotok, D.I., Hogan, P.M., Douglas, G.R. Jr., (1976), Respiratory syncytial virus infection within families. N. Engl. J. Med. 294:414–419.PubMedGoogle Scholar
  3. 3.
    Mufson, M.A., Orvell, C., Rafnar, B., Norrby, E., (1985) Two distinct subtypes of human respiratory syncytial virus. J. Gen. Virol 66: 2111–2124.CrossRefPubMedGoogle Scholar
  4. 4.
    Walsh, E.E., Brandriss, M.W., Schlesinger, J.J., (1987), Immunological differences between the envelope glycoproteins of two strains of human respiratory syncytial virus. J. Gen. Virol. 68: 2169–2176.CrossRefPubMedGoogle Scholar
  5. 5.
    Hendry, R.M., Talis, A.L., Godfrey, E., Anderson, L.J., Fernie, B.F., McIntosh, K., (1986), Concurrent circulation of antigenically distinct strains of respiratory syncytial virus during community outbreaks. J. Infect. Dis. 153: 291–297.PubMedGoogle Scholar
  6. 6.
    Hall, C.B., Walsh, E.E., Schnabel, K.C., Long, C.E., McConnochie, K.M., Hildreth, S.W., Anderson, L.J., (1990), Occurrence of groups A and B of respiratory syncytial virus over 15 years; associated epidemiological and clinical characteristics in hospitalized and ambulatory children. J. Infect. Dis. 162: 1283–1290.PubMedGoogle Scholar
  7. 7.
    Kim, H.W., Canchola, J.G., Brandt, C.D., Pyles, G., Chanock, R.M., Jensen, K., Parrott, R.H., (1969), Respiratory syncytial virus disease in infants despite prior administration of antigenic inactivated vaccine. Am. J. Epidemiol. 89: 422–434.PubMedGoogle Scholar
  8. 8.
    Lamprecht, C.L., Krause, H.E., Mufson, M.A., (1976), Role of maternal antibody in pneumonia and bronchiolitis due to respiratory syncytial virus. J. Infect. Dis. 134: 211–217.PubMedGoogle Scholar
  9. 9.
    Groothuis, J.R., Simoes, E., Levin, M.J., Hall, C.B., Long, C.E., Rodriguez, W.J., Arrobio, J., Meissner, H.C., Fulton, D.R., Wellive, B.C., Tristram, D.A., Siber, G.R., Prince, G.A., VanRaden, M., Hemming, V.A., for The Respiratory Syncytial Virus Immunoglobulin Study Group, (1993), Prophylactic administration of respiratory syncytial virus immune globulin to high-risk infants and young children. The RSVIG Study Group, N. Engl. J. Med. 329:1524–1530.CrossRefPubMedGoogle Scholar
  10. 10.
    The Prevent Study Group, (1977), Reduction of respiratory syncytial virus hospitalization among premature infants and infants with bronchopulmonary dysplasia using respiratory syncytial virus immune globulin prophylaxis. Pediatrics 99: 93–99.CrossRefGoogle Scholar
  11. 11.
    Graham, B.S., Bunton, L.A., Rowland, J., Wright, P.F., Karzon, D.T., (1991), Respiratory syncytial virus infection in anti -μ treated mice. J. Virol. 65: 4936–4942.PubMedGoogle Scholar
  12. 12.
    Welliver, R.C., Wong, D.T., Sun, M., Middleton, E,J.R., Vaugh, R.S., Ogra, P.L., (1981), The development of respiratory syncytial virus-specific IgE and the release of histamine in nasopharyngeal secretions after infections; N. Engl, J.Med. 305: 841–846.Google Scholar
  13. 13.
    Ogra, P.L., (2004), Respiratory syncytial virus: The virus, the disease and the immune response. Pediatr. Resp. Rev. 5 (Suppl A): S119–S126.CrossRefGoogle Scholar
  14. 14.
    Ruuskanen, O., Ogra, P.L., (1993), Respiratory syncytial virus. Curr. Probl. Pediatr. 23: 50–79.CrossRefPubMedGoogle Scholar
  15. 15.
    Welliver, R.C., Kaul, T.N., Putnam, T.I., Sun, M., Riddlesberger, K., Ogra, P.L., (1980), The antibody responses to primary and secondary infection with respiratory syncytial virus: Kinetics of class-specific responses. J. Pediatr. 96: 808–813.CrossRefPubMedGoogle Scholar
  16. 16.
    Kimpen, J.L., Simoes, E.A.F., (2001), Respiratory syncytial virus and reactive airway disease. Am.J. Respir. Crit. Care Med. 163: S1–S6.PubMedGoogle Scholar
  17. 17.
    Englund, J.A., Sullivan, C.J., Jordan, M.C., Dehner, L.P., Vercelloti, G.M., Balfour, H.H. Jr., (1988), Respiratory syncytial virus infection in immunocompromised adults. Ann. Intern. Med. 109: 203–208.PubMedGoogle Scholar
  18. 18.
    Umetsu, D.T., Dekmyff, R.H., (1997), Th1 and Th2 CD4+ cells in the pathogenesis of allergic diseases. Proc. Soc. Exp. Biol. Med. 215: 11–20.PubMedGoogle Scholar
  19. 19.
    Hall, C.B., Long, L.E., Schnabel, K.C., (2001), Respiratory syncytial virus infections in previously healthy working adults. Clin. Infect. Dis. 33: 792–796.CrossRefPubMedGoogle Scholar
  20. 20.
    Freymuth, F., Vabret, A., Gouarin, S., Pettijean, J., Charlonneu, P., Lehoux, P., Galateau-Salle, F., Tremolieres, F., Canette, M.F., Maynaud, C., Mosnier, A., Burnouf, L., (2004), Epidemiology and diagnosis of respiratory syncytial virus in adults. Revu Malad. Respir. 21: 35–42.CrossRefGoogle Scholar
  21. 21.
    Mangtani, P., Hajat, S., Kovats, S., Wilkinson, P., Armstrong, B., (2006). The association of respiratory syncytial virus infection and influenza with emergency admissions for respiratory disease in London: An analysis of routine surveillance data. Clin. Infect. Dis. 42: 640–646.CrossRefPubMedGoogle Scholar
  22. 22.
    Falsey, A.R., Hennessey, P.A., Formica, M., Cox, C., Walsh, E.E., (2005), Respiratory syncytial virus infection in elderly and high-risk adults. N. Engl. J. Med. 352: 1749–1759.CrossRefPubMedGoogle Scholar
  23. 23.
    Sethi. S., Murphy, T.F., (2005), RSV infection - not for kids only (Editorial) N. Engl. J. Med. 352: 1810–1812.CrossRefPubMedGoogle Scholar
  24. 24.
    Flynn, J.D., Akers, W.S., Jones, N., Stevkovic, N., Waid, T., Mullett, T., Jaharia, S., (2004), Treatment of syncytial virus pneumonia in a lung transplant recipient: case report and review of the literature. Pharmacotherapy; 24: 932–938.CrossRefPubMedGoogle Scholar
  25. 25.
    Khushaloni, N.I., Bakri, F.G., Wentling, D., Brown, K., Mohr, A., Anderson, B., Keesler, C., Ball, D., Bernstein, Z.P., Bernstein, S.H., Czuczman., M.S., Segal, B.H., McCarthy, P.L. Jr., (2001), Respiratory syncytial virus infection in the late bone marrow transplant period; report of three cases and review. Bone Marrow Trans. 27: 1071–1073.CrossRefGoogle Scholar
  26. 26.
    Ljungman, P., Ward, K.N., Crooks, B.N., Parker, A., Martino, R., Shaw, P.J., Birch, L., Brune, M., DeLa Camara, R., Dekker, A., Pauksen, K., Russell, N., Schwarer, A.P., Cordonnier, C., (2001), Respiratory virus infections after stem cell transplantation: a prospective study from the Infectious Diseases Working Party of the European Group for Blood and Marrow Transplantation. Bone Marrow Trans. 28: 479–484.CrossRefGoogle Scholar
  27. 27.
    Chakrabarti, S., Avivi, I., Mackinnon, S., Ward, K., Kottaridis, P.D., Osman, H., Waldmann, H., Hale, G., Fegan, C.D., Yong, K., Goldstone, A.H., Linch, D.C., Milligan, D.W., (2002), Respiratory virus infections in transplant recipients after reduced – intensity conditioning with Campath - 1H: high incidence but low mortality. Brit. J. Haematol. 119: 1125–1132.CrossRefGoogle Scholar
  28. 28.
    Khanna, N., Widmer, A.F., Decker, M., Steffen, I., Halter, J., Heim, D., Weisser, M., Gratwohl, A., Fluckiger, U., Hirsch, H., (2008), Respiratory syncytial virus infection in patients with hematological disease; single-center study and review of the literature. Clin. Infect. Dis. 46: 402–412.CrossRefPubMedGoogle Scholar
  29. 29.
    Rovida, F., Percivalle, E., Zavattoni, M., Torsellini, M., Sarasini, A., Companini, G., Paolucci, S., Baldanti, F., Revello, M.G., Gerna, G., (2005), Monoclonal antibodies versus reverse transcription - PCR for detection of respiratory viruses in a patient population with respiratory tract infections admitted to hospital. J. Med. Viral, 75: 336–347.CrossRefGoogle Scholar
  30. 30.
    Anaissie, E.J., Mahfuoz, T.H., Aslam, T., Pouli, A., DesiKan, R., Fassas, A., Barlogie, B., (2004), The natural history of respiratory syncytial virus infection in cancer and transplant patients: implications for management, Blood 103: 1611–1617.CrossRefPubMedGoogle Scholar
  31. 31.
    Englund, J.A., Piedra, P.A., Whimbey, E., (1997), Prevention and treatment of respiratory syncytial virus and parainfluenza viruses in immunocompromised patients, Am. J. Med. 102: 61–70.CrossRefPubMedGoogle Scholar
  32. 32.
    Ottolini, M.G., Porter, D.D., Hemming, V.G., Zimmerman, M.N., Schwab, N.M., Prince, G. A., (1999), Effectiveness of RSV hyperimmune globulin prophylaxis and therapy of respiratory syncytial virus in an immunosuppressed animal model. Bone Marrow Trans. 24: 41–45.CrossRefGoogle Scholar
  33. 33.
    DeVincenzo, J.P., Hirsch, R.L., Fuentes, R.J., Top, F.H., Jr. (2002), Respiratory syncytial virus immune globulin treatment of lower respiratory tract infection in pediatric patients undergoing bone marrow transplantation: a compassionate use experience. Bone Marrow Trans. 25: 161–165.CrossRefGoogle Scholar
  34. 34.
    Zamora, M.R., Hodges, T., Nicholls, M.R., Astor, T.L., Marquesen, J., Weill, D., (2004), Impact of respiratory syncytial virus pneumonia following lung transplantation: a case controlled study. J. Heart Lung Trans. 23(Suppl 2): S43–S441.CrossRefGoogle Scholar
  35. 35.
    Nichols, W.G., Gooley, T., Boeckh, M., (2001), Community- acquired respiratory syncytial virus and parainfluenza virus infections after hematopoietic stem cell transplantation: the Fred Hutchinson Cancer Research Centre experience. Biol. Blood Marrow Trans. 7:115–117.Google Scholar
  36. 36.
    Swedish Consensus Group, (2001), Management of infections caused by respiratory syncytial virus. Scand. J. Infect. Dis. 33: 323–328.CrossRefGoogle Scholar
  37. 37.
    Ljungman P., (2002), Prevention and treatment of viral infections in stem cell transplant recipients. Br. J. Haematol. 118: 44–57.CrossRefPubMedGoogle Scholar
  38. 38.
    Polack, F.P., Kamon, R.A., (2004), The future of respiratory syncytial virus vaccine development. Pediatr. Infect. Dis. J. 23(Suppl): S65–S73.CrossRefPubMedGoogle Scholar
  39. 39.
    Maggon, K., Barik, S., (2004), New drugs and treatment for respiratory virus. Rev. Med. Virol. 14: 149–168.CrossRefPubMedGoogle Scholar
  40. 40.
    Jafri, H.S., (2003), Treatment of respiratory syncytial virus: antiviral therapies. Pediatr. Infect. Dis. J. 22: 589–583.CrossRefGoogle Scholar
  41. 41.
    Boeckh, M., Berrey, M.M., Bowden, R.A., Crawford, S.W., Balsley, J., Corey, L., (2001), Phase I evaluation of the respiratory syncytial virus-specific monodoral antibody palivizumab in recipients of hematopoietic stem cell transplantation. J. Infect. Dis. 184: 350–354.CrossRefPubMedGoogle Scholar
  42. 42.
    Kamon, R.A., Wright, P.F., Belshe, R.B., Thumar, B., Casey, R., Newman, F., Polack, F.P., Randolph, V.B., Dently, A., Hackell, T., Gruber, W., Murphy, B.R., Collins, P.L., (2005), Identification of a recombinant live attenuated respiratory syncytial virus vaccine candidate that is highly attenuated in infants. J. Infect. Dis. 191: 1093–1104.CrossRefGoogle Scholar
  43. 43.
    Power, U.F., Nguyen, T.N., Rietveld, E., de Swart, R.L., Groen, J., Osterhaus, A.D., deGroot, R., Corvaia, N., Beck, A., Bouveret-Le-Cam, N., Bonnefoy, J.Y., (2001), Safety and immu-nogenicity of a novel recombinant subunit respiratory syncytial virus vaccine (BBG2Na) in healthy young adults. J. Infect. Dis. 184: 1456–1460.CrossRefPubMedGoogle Scholar
  44. 44.
    Plotnicky-Gilquin, H., Cyblat-Chanal, D., Goetsch, L., Lacheny, C., Libon, C., Champion, T., Beck, A., Pasche, H., Nguyen, T.N., Bonnefoy, J.Y., Bouveret-Le-Cam, N., Corvaia, N., (2002), Passive transfer of serum antibodies induced by BBG2Na, a subunit vaccine, in the elderly protects SCID mouse lungs against respiratory syncytial virus challenge. Virology 303: 130;–137.CrossRefPubMedGoogle Scholar
  45. 45.
    Torrence, P.F., Powell, L.D., (2002), The quest for an efficacious antiviral for respiratory syncytial virus. Antiviral Chem. Chemother. 13: 325–344.Google Scholar
  46. 46.
    Boeckh, M., Englund, J., Li, Y., Miller, C., Cross, A., Fernandez, H., Kuypers, J., Kim, H., Gnann, J., Whitley, R., NIAD Collaborative Antiviral Study Group, (2007), Randomized controlled multicenter trial of aerolized ribavirin for respiratory syncytial virus upper respiratory tract infection in hematopoietic cell transplant recipients. Clin. Infect. Dis. 44: 235–249.CrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2009

Personalised recommendations